Jonathan Stuart Foot

USPTO Granted Patents = 9 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Glasgow, GB (2013)
New South Wales, AU (2016 - 2018)
Frenchs Forest, AU (2020 - 2021)

Company Filing History:

Boehringer Ingelheim International Gmbh

Years Active: 2013-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428370 - Haloallylamine dual amine oxidase inhibitors (2025-09-30),

2. 12178791 - Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof (2024-12-31),

3. 11098045 - Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof (2021-08-24),

4. 10717734 - Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof (2020-07-21),

5. 10717733 - Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof (2020-07-21),

6. 10160723 - Substituted 3-haloallylamine inhibitors of SSAO and uses thereof (2018-12-25),

7. 9815782 - Substituted 3-haloallylamine inhibitors of SSAO and uses thereof (2017-11-14),

8. 9302986 - Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof (2016-04-05),

9. 8426587 - Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor (2013-04-23),

Title: Innovations of Jonathan Stuart Foot

Introduction

Jonathan Stuart Foot is an accomplished inventor based in Frenchs Forest, Australia. He holds a total of nine patents, showcasing his significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing novel compounds that target various neuromuscular and neuroinflammatory diseases.

Latest Patents

One of his latest patents is titled "Haloallylamine dual amine oxidase inhibitors." This invention relates to novel compounds capable of inhibiting semicarbazide-sensitive amine oxidase (SSAO/VAP-1) and monoamine oxidase B (MAO-B). These compounds are particularly useful for treating a variety of neuromuscular diseases, such as muscular dystrophies, and neuroinflammatory diseases affecting both peripheral and central systems in humans, pets, and livestock. Another significant patent is "Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof." This invention also focuses on novel compounds that inhibit certain amine oxidase enzymes, which can be beneficial in treating conditions like fibrosis, cancer, and angiogenesis in both humans and animals.

Career Highlights

Throughout his career, Jonathan has worked with notable companies such as Pharmaxis Ltd. and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Jonathan has collaborated with several professionals in his field, including Mandar Deodhar and Craig Ivan Turner. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Jonathan Stuart Foot's innovative work in the pharmaceutical industry has led to significant advancements in the treatment of various diseases. His contributions through his patents reflect his dedication to improving health outcomes for both humans and animals.

This text is generated by artificial intelligence and may not be accurate.